Earnings Call · Q3 FY2022·2022-11-09

Q3 22EPS +11.11%·Rev n/aQ2 22EPS +13.33%·Rev n/aQ1 22EPS +30.00%·Rev n/aQ4 21EPS +21.05%·Rev n/a⚠ consensus missing

Arbutus Biopharma Corp ABUS

Lisa Caperelli — Investor Relations

Bill Collier — President and Chief Executive Officer

David Hastings — Chief Financial Officer

−0.8%1d on move date+1.2% vs SPY3d+4.1%5d+13.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABUS calls or request research access.

More ABUS calls Browse calls Request research access